ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

NCI Director Halts STELLAR Trial, Seeks “Brilliant Ideas” For Breast Cancer Prevention.

March 2, 2007

HCFA Disregards Pleas From Centers, ACCC, Sen. Dole, NCAB, AACI; Final DRG Regulations Made Even Tougher

January 13, 1984

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

Interview: “People don’t understand Clinical Trials.

September 5, 1997

NIH Solicits Grant applications For New Type Of Small Business Award; 40 To Be Funded

September 10, 1993